Access state of the art technologies to facilitate immunology research
Whether you need to generate a tool for your immunology project, or develop a therapy to assess for translational potential, the groups within this Platform have the required expertise
Cellular screening facility
Led by Daniel Ebner at the TDI, the cellular screening facility use multiple screening techniques to identify novel targets for potential therapeutic development. This includes cell-based arrayed small compound screens and CRISPR/Cas9 genome-wide screens. Please contact Daniel Ebner for advice on how this facility can help your immunology project.
Monoclonal antibody facility
Led by Alison Banham, head of NDCLS, the monoclonal antibody facility has significant experience in the development, validation and characterisation of monoclonal antibodies. Please contact Amanda Anderson, the facility manager, for more information.